The growth of co-transformed cells in the peritoneal cavity alters viral gene expression to mirror that of PEL cell lines. by Mitchell Hayes (5334887)

S1 File - A novel yeast-derived aldehyde-reducing compound MF001 protects against alcohol-induced liver damage by Eun-Ho Lee (2696890)

Subjects:

Sexual maturity status of female C57BL/6J Mice at different ages. by Yan She (8639796)

Subjects:

Flow chart of data screening and analysis. by Yan She (8639796)

Subjects:

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

Modeling results of 8-week-old female C57BL/6J mice. by Yan She (8639796)

Subjects:

Heterogeneity analysis. by Ying Zhao (16546)

Subjects:

Reverse MR analysis data. by Ying Zhao (16546)

Subjects:

SNP dressing by screening. by Ying Zhao (16546)

Subjects:

Presents the bibliometric search results. by Yan She (8639796)

Subjects:

Sensitivity analysis. by Ying Zhao (16546)

Subjects:

Readability scores for Chatgpt-4o, Gemini, and Perplexity responses to the most frequently asked Ankylosing spondylitis -related questions, and a statistical comparison of the text... by Mete Kara (21568148)

Subjects:

TG protein modeling. by Wendy J. Bailey (14926392)

Subjects:

Impact of the interaction between sewage pH and CPAM dosage on sewage turbidity. (a) Contour diagram; (b) 3D surface diagram. by Peng Zhao (128233)

Subjects:

Impact of group 1 and group 2 drugs on hyperglycemia based on HbA1c levels before and after 3 months of administration. by Nadia Gul (249538)

Subjects:

Co-transformed cells grow preferentially as tumors in peritoneal cavities. by Mitchell Hayes (5334887)

Microflow Liquid Chromatography Coupled to Multinozzle Electrospray Ionization for Improved Lipidomics Coverage of 3D Clear Cell Renal Cell Carcinoma by Sergey Girel (6887840)

Subjects:

BFD2 aggravates the inflammatory response to <i>Toxoplasma gondii</i> infection. by Xiaocheng Zhang (3140460)

Subjects:

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

“…A representative HPD <b>1466</b>, with a 50% effective concentration against HBV replication of 0.25 µM, decreased capsid and core protein accumulation by 50–90% in HepDES19 and HepG2.2.15 cells. …”

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)